Identifying lifelong factors that impact brain health and functional outcomes in adults with childhood-onset type 1 diabetes: the cognition and longitudinal assessments of risk factors over 30 years (CLARiFY) – diabetes complications study protocol

Introduction Type 1 diabetes (T1D) is associated with changes in brain structure, cognition, mental health, and functional outcomes. While these changes have been linked to dysregulated glycaemic control, findings are inconsistent, and their long-term impact remains unclear. Most evidence comes from...

Full description

Saved in:
Bibliographic Details
Main Authors: Velandai K Srikanth, Eva L Feldman, Chris Moran, Lili Zhao, Amy Brown, Richard Beare, Elisabeth A Northam, Emily J Koubek, Stacey A Sakowski, Taya Collyer, Chris L. Adamson, Fergus J. Cameron
Format: Article
Language:English
Published: BMJ Publishing Group 2025-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/6/e105887.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839651590905004032
author Velandai K Srikanth
Eva L Feldman
Chris Moran
Lili Zhao
Amy Brown
Richard Beare
Elisabeth A Northam
Emily J Koubek
Stacey A Sakowski
Taya Collyer
Chris L. Adamson
Fergus J. Cameron
author_facet Velandai K Srikanth
Eva L Feldman
Chris Moran
Lili Zhao
Amy Brown
Richard Beare
Elisabeth A Northam
Emily J Koubek
Stacey A Sakowski
Taya Collyer
Chris L. Adamson
Fergus J. Cameron
author_sort Velandai K Srikanth
collection DOAJ
description Introduction Type 1 diabetes (T1D) is associated with changes in brain structure, cognition, mental health, and functional outcomes. While these changes have been linked to dysregulated glycaemic control, findings are inconsistent, and their long-term impact remains unclear. Most evidence comes from cross-sectional or short-term longitudinal studies, limiting insights into causal associations. To address this, we aim to study individuals with T1D approximately 30 years after onset to assess how early dysglycaemic insults during neurodevelopment influence cognitive and functional outcomes in mid-adulthood.Methods and analysis This protocol paper outlines an observational, case/control, cross-sectional/longitudinal and descriptive study that follows up the original Royal Children’s Hospital (RCH) Diabetes Cohort Study. The initial study recruited children in Australia diagnosed with T1D between 1990 and 1992, conducting five waves of data collection. We now introduce the Cognition and Longitudinal Assessments of Risk Factors over 30 Years (CLARiFY) Diabetes Complications Study to assess brain, cognition and functional outcomes in mid-adulthood, approximately 30 years post-T1D onset. Both T1D participants from the original cohort and healthy controls will participate in semistructured interviews, neuroimaging and cognitive testing. T1D participants will also undergo complications screening. Data from this study and previous waves will be used to (Aim 1) explore cross-sectional and longitudinal impacts of T1D on brain health over 30 years. Linear regression will analyse cross-sectional outcomes, and multivariate analysis will assess cognitive variables jointly. Longitudinal outcomes will be examined using linear mixed-effects regression for IQ patterns, with secondary outcomes analysed via generalised linear models. Additionally, linear mixed-effects regression (Aim 2) will identify T1D-related metabolic factors affecting brain outcomes, with covariate selection informed by the construction of directed acyclic graphs (DAGs).Ethics and dissemination The study was approved by the Royal Children’s Hospital Human Research Ethics Committee (HREC 35 240F and 2019.065). The research findings will be disseminated through peer-reviewed publications, conference presentations, and print and social media. Participants will receive a summary of the study findings on its completion.
format Article
id doaj-art-9e7a1f9e7d2a49f0ae87af6a805f7c46
institution Matheson Library
issn 2044-6055
language English
publishDate 2025-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-9e7a1f9e7d2a49f0ae87af6a805f7c462025-06-26T04:20:11ZengBMJ Publishing GroupBMJ Open2044-60552025-06-0115610.1136/bmjopen-2025-105887Identifying lifelong factors that impact brain health and functional outcomes in adults with childhood-onset type 1 diabetes: the cognition and longitudinal assessments of risk factors over 30 years (CLARiFY) – diabetes complications study protocolVelandai K Srikanth0Eva L Feldman1Chris Moran2Lili Zhao3Amy Brown4Richard Beare5Elisabeth A Northam6Emily J Koubek7Stacey A Sakowski8Taya Collyer9Chris L. Adamson10Fergus J. Cameron11Peninsula Clinical School, Monash University, Frankston, Victoria, AustraliaDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USANational Centre for Healthy Ageing, Frankston, Victoria, AustraliaPreventative Medicine - Biostatistics Division, Northwestern University, Chicago, Illinois, USAMurdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Victoria, AustraliaNational Centre for Healthy Ageing, Frankston, Victoria, AustraliaMurdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Victoria, AustraliaDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USADepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USANational Centre for Healthy Ageing, Frankston, Victoria, AustraliaMurdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Victoria, AustraliaMurdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Victoria, AustraliaIntroduction Type 1 diabetes (T1D) is associated with changes in brain structure, cognition, mental health, and functional outcomes. While these changes have been linked to dysregulated glycaemic control, findings are inconsistent, and their long-term impact remains unclear. Most evidence comes from cross-sectional or short-term longitudinal studies, limiting insights into causal associations. To address this, we aim to study individuals with T1D approximately 30 years after onset to assess how early dysglycaemic insults during neurodevelopment influence cognitive and functional outcomes in mid-adulthood.Methods and analysis This protocol paper outlines an observational, case/control, cross-sectional/longitudinal and descriptive study that follows up the original Royal Children’s Hospital (RCH) Diabetes Cohort Study. The initial study recruited children in Australia diagnosed with T1D between 1990 and 1992, conducting five waves of data collection. We now introduce the Cognition and Longitudinal Assessments of Risk Factors over 30 Years (CLARiFY) Diabetes Complications Study to assess brain, cognition and functional outcomes in mid-adulthood, approximately 30 years post-T1D onset. Both T1D participants from the original cohort and healthy controls will participate in semistructured interviews, neuroimaging and cognitive testing. T1D participants will also undergo complications screening. Data from this study and previous waves will be used to (Aim 1) explore cross-sectional and longitudinal impacts of T1D on brain health over 30 years. Linear regression will analyse cross-sectional outcomes, and multivariate analysis will assess cognitive variables jointly. Longitudinal outcomes will be examined using linear mixed-effects regression for IQ patterns, with secondary outcomes analysed via generalised linear models. Additionally, linear mixed-effects regression (Aim 2) will identify T1D-related metabolic factors affecting brain outcomes, with covariate selection informed by the construction of directed acyclic graphs (DAGs).Ethics and dissemination The study was approved by the Royal Children’s Hospital Human Research Ethics Committee (HREC 35 240F and 2019.065). The research findings will be disseminated through peer-reviewed publications, conference presentations, and print and social media. Participants will receive a summary of the study findings on its completion.https://bmjopen.bmj.com/content/15/6/e105887.full
spellingShingle Velandai K Srikanth
Eva L Feldman
Chris Moran
Lili Zhao
Amy Brown
Richard Beare
Elisabeth A Northam
Emily J Koubek
Stacey A Sakowski
Taya Collyer
Chris L. Adamson
Fergus J. Cameron
Identifying lifelong factors that impact brain health and functional outcomes in adults with childhood-onset type 1 diabetes: the cognition and longitudinal assessments of risk factors over 30 years (CLARiFY) – diabetes complications study protocol
BMJ Open
title Identifying lifelong factors that impact brain health and functional outcomes in adults with childhood-onset type 1 diabetes: the cognition and longitudinal assessments of risk factors over 30 years (CLARiFY) – diabetes complications study protocol
title_full Identifying lifelong factors that impact brain health and functional outcomes in adults with childhood-onset type 1 diabetes: the cognition and longitudinal assessments of risk factors over 30 years (CLARiFY) – diabetes complications study protocol
title_fullStr Identifying lifelong factors that impact brain health and functional outcomes in adults with childhood-onset type 1 diabetes: the cognition and longitudinal assessments of risk factors over 30 years (CLARiFY) – diabetes complications study protocol
title_full_unstemmed Identifying lifelong factors that impact brain health and functional outcomes in adults with childhood-onset type 1 diabetes: the cognition and longitudinal assessments of risk factors over 30 years (CLARiFY) – diabetes complications study protocol
title_short Identifying lifelong factors that impact brain health and functional outcomes in adults with childhood-onset type 1 diabetes: the cognition and longitudinal assessments of risk factors over 30 years (CLARiFY) – diabetes complications study protocol
title_sort identifying lifelong factors that impact brain health and functional outcomes in adults with childhood onset type 1 diabetes the cognition and longitudinal assessments of risk factors over 30 years clarify diabetes complications study protocol
url https://bmjopen.bmj.com/content/15/6/e105887.full
work_keys_str_mv AT velandaiksrikanth identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT evalfeldman identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT chrismoran identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT lilizhao identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT amybrown identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT richardbeare identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT elisabethanortham identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT emilyjkoubek identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT staceyasakowski identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT tayacollyer identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT chrisladamson identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol
AT fergusjcameron identifyinglifelongfactorsthatimpactbrainhealthandfunctionaloutcomesinadultswithchildhoodonsettype1diabetesthecognitionandlongitudinalassessmentsofriskfactorsover30yearsclarifydiabetescomplicationsstudyprotocol